259 related articles for article (PubMed ID: 30898070)
1. A Comparative Cost-Effectiveness Analysis of Percutaneous Transluminal Angioplasty With Optional Stenting and Femoropopliteal Bypass Surgery for Medium-Length TASC II B and C Femoropopliteal Lesions.
Vossen RJ; Philipszoon PC; Vahl AC; Montauban van Swijndregt AD; Leijdekkers VJ; Balm R
J Endovasc Ther; 2019 Apr; 26(2):172-180. PubMed ID: 30898070
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
[TBL] [Abstract][Full Text] [Related]
3. Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.
Dosluoglu HH; Cherr GS; Lall P; Harris LM; Dryjski ML
J Vasc Surg; 2008 Nov; 48(5):1166-74. PubMed ID: 18692357
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
[TBL] [Abstract][Full Text] [Related]
5. Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.
Biagioni RB; Brandão GD; Biagioni LC; Nasser F; Burihan MC; Ingrund JC
J Vasc Surg; 2019 May; 69(5):1510-1518. PubMed ID: 30611581
[TBL] [Abstract][Full Text] [Related]
6. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
[TBL] [Abstract][Full Text] [Related]
7. PTA and Stenting of Femoropopliteal Trunk With Cordis Smartflex Stent System: A Single-Center Experience.
Garriboli L; Miccoli T; Pruner G; Jannello AM
Vasc Endovascular Surg; 2020 Jan; 54(1):17-24. PubMed ID: 31526118
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty: Results From the IN.PACT SFA II Trial.
Salisbury AC; Li H; Vilain KR; Jaff MR; Schneider PA; Laird JR; Cohen DJ
JACC Cardiovasc Interv; 2016 Nov; 9(22):2343-2352. PubMed ID: 27884360
[TBL] [Abstract][Full Text] [Related]
9. Endovascular Intervention for the Treatment of Trans-Atlantic Inter-Society Consensus (TASC) D Femoropopliteal Lesions: A Systematic Review and Meta-Analysis.
Giannopoulos S; Lyden SP; Bisdas T; Micari A; Parikh SA; Jaff MR; Schneider PA; Armstrong EJ
Cardiovasc Revasc Med; 2021 Jan; 22():52-65. PubMed ID: 32563709
[TBL] [Abstract][Full Text] [Related]
10. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
Chan YC; Cheng SW; Cheung GC
J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
[TBL] [Abstract][Full Text] [Related]
11. Impact of Scoring Balloons on Percutaneous Transluminal Angioplasty Outcomes in Femoropopliteal Lesions.
Horie K; Tanaka A; Taguri M; Inoue N
J Endovasc Ther; 2020 Jun; 27(3):481-491. PubMed ID: 32249658
[No Abstract] [Full Text] [Related]
12. ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions.
Bosiers M; Setacci C; De Donato G; Torsello G; Silveira PG; Deloose K; Scheinert D; Veroux P; Hendriks J; Maene L; Keirse K; Navarro T; Callaert J; Eckstein HH; Teβarek J; Giaquinta A; Wauters J
J Endovasc Ther; 2020 Apr; 27(2):287-295. PubMed ID: 31997715
[No Abstract] [Full Text] [Related]
13. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions.
Baril DT; Marone LK; Kim J; Go MR; Chaer RA; Rhee RY
J Vasc Surg; 2008 Sep; 48(3):627-33. PubMed ID: 18727966
[TBL] [Abstract][Full Text] [Related]
15. The association of statin therapy with the primary patency of femoral and popliteal artery stents.
de Grijs D; Teixeira P; Katz S
J Vasc Surg; 2018 May; 67(5):1472-1479. PubMed ID: 29224939
[TBL] [Abstract][Full Text] [Related]
16. Primary stenting of the superficial femoral and popliteal artery.
Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous angioplasty and stenting of the superficial femoral artery.
Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
19. Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease.
Malas MB; Enwerem N; Qazi U; Brown B; Schneider EB; Reifsnyder T; Freischlag JA; Perler BA
J Vasc Surg; 2014 Jan; 59(1):129-35. PubMed ID: 23891488
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Atherectomy to Balloon Angioplasty and Stenting for Isolated Femoropopliteal Revascularization.
Bai H; Fereydooni A; Zhuo H; Zhang Y; Tonnessen BH; Guzman RJ; Ochoa Chaar CI
Ann Vasc Surg; 2020 Nov; 69():261-273. PubMed ID: 32512112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
